NCT06895044

Brief Summary

Myopia and high myopia are the leading causes of visual impairment and blindness worldwide. The total number of myopic people globally was estimated to be 2.6 billion in 2020, and it could reach 4.8 billion by 2050 unless preventive interventions are implemented. Strategies to slow the progression of myopia, such as contact lenses, orthokeratology, atropine, and increased time spent outdoors, have shown promising results, although evidence varies depending on the method. However, most research has been conducted in Asia, and there are few studies on ocular growth in myopic children in Europe. Meanwhile, the prevalence of myopia is also increasing significantly in Europe, particularly in France. Understanding the growth of the myopic eye in European children is crucial. Cohort studies of myopic children are scarce and do not always include high-quality imaging. A cohort of myopic children with prospective collection of the best retinal and corneal images, along with ophthalmological exams to detail and model the growth of the myopic eye, will provide valuable insights to enhance our understanding of ocular growth and its inter-individual variability.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
82mo left

Started Apr 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Apr 2025Apr 2033

First Submitted

Initial submission to the registry

March 19, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 26, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

April 30, 2025

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2033

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2033

Last Updated

December 4, 2025

Status Verified

December 1, 2025

Enrollment Period

8 years

First QC Date

March 19, 2025

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • axial length

    Measurement of axial length by IOL Master

    Year 5

Interventions

alls exams included in ophtalmologic follow-up every 6 months for 5 years

all exams included in ophtalmological follow-up including axial length mesurment every 6 moths

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 6 to 17 years at inclusion, diagnosed with myopia (refractive error of -0.5 D or less in spherical equivalent in at least one eye)

You may qualify if:

  • Myopia in at least one eye, defined as a refractive error in spherical equivalent ≤ -0.50 diopters (autorefraction under cycloplegia)
  • Affiliated or beneficiary of a social security system
  • Explicit consent from a holder of parental authority

You may not qualify if:

  • Presence of trauma in both eyes
  • Presence of inflammatory conditions in both eyes
  • History of intraocular surgery (cataract, filtering surgery, intra-vitreal surgery) in both eyes
  • Patient benefiting from legal protection measures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Fondation A. de Rothschild

Paris, 75019, France

RECRUITING

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Thibaut Chapron, Dr

    Hôpital Fondation Adolphe de Rothschild

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amelie Yavchitz

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2025

First Posted

March 26, 2025

Study Start

April 30, 2025

Primary Completion (Estimated)

April 30, 2033

Study Completion (Estimated)

April 30, 2033

Last Updated

December 4, 2025

Record last verified: 2025-12

Locations